Objective: This study quantifies the change in collision avoidance performance of autonomous emergency braking (AEB) systems for traffic accidents in Japan since 2015.
Method: This study used data on Japanese traffic accidents compiled by Japan's National Police Agency. The data included only accidents involving loss of or injury to human life; accidents involving only property damage were excluded. We restricted our analysis to collisions between two 4-wheel vehicles and considered only collisions for which we could determine whether the primary party's car was equipped with an AEB system. Both Poisson and negative binomial mixed-effects regression analyses were conducted using the data for 2021 and 2022 to measure the collision avoidance performance of first registered cars in 2015 to 2020 equipped with AEB systems compared with cars without AEB systems first registered in 2015. Collision avoidance performance was measured for 2 types of intervehicle collisions: rear-end collisions and right-turn collisions. Collision avoidance performance for rear-end collisions was also measured for each of the 3 car types-Standard, small, and light cars.
Results: The collision reduction rate for rear-end collisions increases with the year of first registration and for cars equipped with AEB systems first registered in 2020 compared with non-AEB-equipped cars first registered in 2015 is 69.2% (95% confidence interval [CI] 67.0%-71.1%), indicating that the performance of AEB systems has dramatically improved in terms of preventing rear-end collisions. For right-turn collisions, the rate increased to 20.4% (95% CI 5.9%-32.6%) for cars equipped with AEB systems first registered in 2019. However, no clear trend is observed.
Conclusions: This study evaluated a time series of the collision reduction performance of AEB systems using an original methodology. Japan's New Car Assessment Program (JNCAP) has included AEB's effectiveness in reducing damage from traffic collisions as an evaluation item since FY2014. The results could demonstrate the effectiveness of JNCAP.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/15389588.2024.2394975 | DOI Listing |
Clin Pharmacokinet
December 2024
Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
Background And Objective: We conducted an opportunistic pharmacokinetic study to evaluate the population pharmacokinetics of meropenem, an antimicrobial commonly used to treat Gram-negative infections in adults of different ages, including older adults, and determined optimal dosing regimens.
Methods: A total of 99 patients were included. The population pharmacokinetic models used had two compartments: zero-order input and linear elimination.
JAMIA Open
December 2024
Department of Biomedical Informatics, University of California San Diego, La Jolla, CA 92093, United States.
Objectives: This study describes the development and deployment of a machine learning (ML) model called Vent.io to predict mechanical ventilation (MV).
Materials And Methods: We trained Vent.
Accid Anal Prev
December 2024
School of Vehicle and Mobility, State Key Laboratory of Intelligent Green Vehicle and Mobility, Tsinghua University, Beijing 100084, China. Electronic address:
Intelligent safety systems (ISS) for autonomous vehicles, integrating advanced perception capabilities and passive protection devices, are expected to reshape traditional pedestrian safety systems and play a key role in reducing the risk of pedestrian injuries in traffic accidents. However, traditional active control and passive protection modules remain disconnected due to insufficient evidence supporting the effectiveness of collaborative strategies in integrated systems, particularly concerning activation criteria and timing. This study aims to address this gap by developing a comprehensive ISS that incorporates advanced perception systems, a vehicle dynamic control module, and controllable passive safety devices.
View Article and Find Full Text PDFCirc Arrhythm Electrophysiol
December 2024
Department of Cardiology, Amsterdam UMC Location University of Amsterdam, Heart Center, Amsterdam Cardiovascular Sciences Heart failure and Arrhythmias, the Netherlands (L.R.A.O.N., S.P., L.V.A.B., T.F.B., A.-F.B.E.Q., W.v.d.S., L.S., J.A.d.V., J.G.P.T., N.R.B., J.R.d.G., K.M.K., A.d.W., A.A.M.W., R.E.K.).
Circ Cardiovasc Qual Outcomes
November 2024
Department of Cardiology, Amsterdam Cardiovascular Sciences Heart Failure and Arrhythmias, Amsterdam University Medical Centers Location University of Amsterdam, Heart Center, the Netherlands (R.E.K., J.A.d.V., L.V.A.B., T.F.B., S.P., A.-F.B.E.Q., L.S., W.v.d.S., A.d.W., J.R.d.G., K.M.K., J.G.P.T., A.A.M.W., L.R.A.O.N.).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!